TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias (2018)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1530/ERC-17-0286
- Subjects: NEUROFIBROMATOSES; DIAGNÓSTICO POR COMPUTADOR; MUTAÇÃO GENÉTICA; NEOPLASIA ENDÓCRINA MÚLTIPLA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Endocrine-related cancer
- ISSN: 1351-0088
- Volume/Número/Paginação/Ano: v. 25, n. 2, p. L1-L5, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ASPRINO, Paula Fontes e HOFF, Paulo Marcelo Gehm. TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias. Endocrine-related cancer, v. 25, n. 2, p. L1-L5, 2018Tradução . . Disponível em: https://doi.org/10.1530/ERC-17-0286. Acesso em: 18 fev. 2026. -
APA
Asprino, P. F., & Hoff, P. M. G. (2018). TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias. Endocrine-related cancer, 25( 2), L1-L5. doi:10.1530/ERC-17-0286 -
NLM
Asprino PF, Hoff PMG. TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias [Internet]. Endocrine-related cancer. 2018 ; 25( 2): L1-L5.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1530/ERC-17-0286 -
Vancouver
Asprino PF, Hoff PMG. TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias [Internet]. Endocrine-related cancer. 2018 ; 25( 2): L1-L5.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1530/ERC-17-0286 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.1530/ERC-17-0286 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
